Follow
Chen Lu
Chen Lu
Biostatistics Sr Manager, Amgen Inc.
Verified email at bu.edu
Title
Cited by
Cited by
Year
Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts
KS Vimaleswaran, DJ Berry, C Lu, E Tikkanen, S Pilz, LT Hiraki, ...
PLoS Med 10 (2), e1001383, 2013
11972013
Meta-analysis of genome-wide association studies in> 80 000 subjects identifies multiple loci for C-reactive protein levels
A Dehghan, J Dupuis, M Barbalic, JC Bis, G Eiriksdottir, C Lu, N Pellikka, ...
Circulation 123 (7), 731-738, 2011
5822011
Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study
KS Vimaleswaran, A Cavadino, DJ Berry, R Jorde, AK Dieffenbach, C Lu, ...
The Lancet Diabetes & Endocrinology 2 (9), 719-729, 2014
4432014
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels
M Barbalic, J Dupuis, A Dehghan, JC Bis, RC Hoogeveen, RB Schnabel, ...
Human molecular genetics, ddq061, 2010
3072010
Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
JE Ho, WY Chen, MH Chen, MG Larson, EL McCabe, S Cheng, ...
The Journal of clinical investigation 123 (10), 4208-4218, 2013
1582013
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association …
H Grallert, J Dupuis, JC Bis, A Dehghan, M Barbalic, J Baumert, C Lu, ...
European heart journal, ehr372, 2011
1252011
Efficacy, safety, and tolerability of evolocumab in pediatric patients with heterozygous familial hypercholesterolemia: Rationale and design of the HAUSER-RCT study
D Gaudet, G Langslet, SS Gidding, IK Luirink, A Ruzza, C Kurtz, C Lu, ...
Journal of clinical lipidology 12 (5), 1199-1207, 2018
402018
Pathway analysis following association study
JS Ngwa, AK Manning, JL Grimsby, C Lu, WV Zhuang, AL DeStefano
BMC proceedings 5 (9), 1, 2011
232011
Pancreatic beta-cell function and type 2 diabetes risk: quantify the causal effect using a Mendelian randomization approach based on meta-analyses
Y Song, E Yeung, A Liu, TJ VanderWeele, L Chen, C Lu, C Liu, ...
Human molecular genetics 21 (22), 5010-5018, 2012
222012
Evolocumab vs. ezetimibe in statin-intolerant hyperlipidemic Japanese patients: phase 3 GAUSS-4 trial
S Koba, I Inoue, M Cyrille, C Lu, H Inomata, J Shimauchi, K Kajinami
Journal of atherosclerosis and thrombosis, 50963, 2019
212019
Network-guided sparse regression modeling for detection of gene-by-gene interactions
C Lu, J Latourelle, GT O’Connor, J Dupuis, ED Kolaczyk
Bioinformatics, btt139, 2013
82013
Rare genetic variant analysis on blood pressure in related samples
H Chen, SH Choi, J Hong, C Lu, JN Milton, C Allard, SM Lacey, H Lin, ...
BMC proceedings 8 (1), 1, 2014
62014
Long-Term Treatment With Evolocumab Among Japanese Patients―Final Report of the OSLER Open-Label Extension Studies―
A Hirayama, S Yamashita, A Ruzza, H Inomata, M Cyrille, C Lu, ...
Circulation Journal 83 (5), 971-977, 2019
52019
Meta-Analysis for Penalized Regression Methods with Multi-Cohort Genome-Wide Association Studies
C Lu, GT O'Connor, J Dupuis, ED Kolaczyk
Human heredity 81 (3), 142-149, 2016
32016
A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
DE Lanfear, KR Neaton, C Lu, Y Liu, RE Dent-Acosta
Cardiology and therapy 9 (2), 561-568, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–15